Catalyst Wire Dossier Catalyst Wire Dossier

GLS4

GLS4 · Sunshine Lake Pharma Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GLS4, covering 2024-06-21 to 2024-06-21. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection [Phase 2]

See pricing